9 unknown, 7 completed, 3 terminated, 2 withdrawn. 22 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 22 | Unknown 9, Completed 7, Terminated 3, Withdrawn 2, Recruiting 1 |
Follow Iron-deficiency: new trials by email Literature Review of Iron-deficiency trials Research Report on Iron-deficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart Failure Sucrosomial iron, Placebo - Chronic Heart Failure, Iron-deficiency | Phase 4 | Recruiting | Raffaele De Caterina | 60 | 2024-03-14 | 2025-10-01 |
| Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure IV Iron Infusion Group - Heart Failure, Iron-deficiency | Phase 4 | Terminated | Radha Gopalan | 6 | 2024-01-24 | 2026-07-29 |
| Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency Sucrosomial iron, Vitamin D, Ferric Carboxymaltose 50 MG/ML - Heart Failure, Iron-deficiency | Phase 4 | Unknown | University of Padova | 258 | 2024-01-15 | 2023-12-15 |
| The Impact of Nutrition Education and Milk Provision in Fueling the Progress of 1 - 3 Years Old Children Nutrition Education and Growing Up Milk for 1 - 3 years old, Nutrition Education - Iron-deficiency | Phase 4 | Unknown | Danone Specialized Nutrition Indonesia | 196 | 2022-08-31 | 2022-08-15 |
| Predicting Response to Iron Supplementation in Patients With Active Inflammatory Bowel Disease Intravenous iron, Ferric maltol, Ferrous fumarate - Inflammatory Bowel Diseases, Iron-deficiency | Phase 4 | Unknown | Leiden University Medical Center | 90 | 2022-08-19 | 2023-03-31 |
| Iron Supplementation in TAVI and SAVR Patients With Iron Deficiency Ferric carboxymaltose - Aortic Stenosis, Iron-deficiency | Phase 4 | Unknown | Hospital de Santa Cruz, Portugal | 2500 | 2022-01-01 | 2021-03-08 |
| Iron Substitution With Ferric Carboxymaltose as Treatment Strategy for Heart Failure Patients With Preserved Ejection Fraction Ferric carboxymaltose, Placebo - Heart Failure With Normal Ejection Fraction, Iron-deficiency | Phase 4 | Withdrawn | Cantonal Hospital, Baselland | 2021-12-01 | 2022-07-28 | |
| Ferric Carboxymaltose With or Without Phosphate Substitution for the Treatment of Iron Deficiency or Iron Deficiency Anemia Verum, Placebo - Anemia, Iron-deficiency | Phase 4 | Completed | Donat R. Spahn | 92 | 2021-11-11 | 2023-05-24 |
| Oral Iron Frequency for Childhood Restless Leg Syndrome/Periodic Limb Movement Disorder Ferrous sulfate - Sleep Disorder, Restless Legs Syndrome | Phase 4 | Terminated | Mayo Clinic | 6 | 2020-11-16 | 2024-05-22 |
| The Iron and Muscle Study Ferinject, Placebo: NaCl (sodium chloride 0.9%) - CKD Stage 3, CKD Stage 4 | Phase 4 | Completed | King's College Hospital NHS Trust | 75 | 2019-04-26 | 2022-03-02 |
| Intravenous Iron in Adults With Cystic Fibrosis Ferric carboxymaltose - Cystic Fibrosis, Iron-deficiency | Phase 4 | Completed | University of Oxford | 20 | 2019-02-22 | 2022-09-07 |
| the Effectiveness of Lactoferrin in Treatment of Iron Deficiency Anemia in Children With Chronic Tonsillitis Lactoferrin, Ferric Hydroxide Polymaltose - Iron-deficiency | Phase 4 | Unknown | South Valley University | 100 | 2019-02-21 | 2019-03-19 |
| Oral Lactoferrin Versus Iron Supplementation During Pregnancy Lactoferrin, Iron Supplement, Chelates, Iron - Iron-deficiency | Phase 4 | Completed | South Valley University | 300 | 2018-01-01 | 2018-12-28 |
| Evaluating Iron Protein Succinylate Oral Solution in Treating Chronic Heart Failure and Iron Deficiency Iron protein succinylate oral solution, standard treatment - Chronic Heart Failure, Iron-deficiency | Phase 4 | Unknown | Lee's Pharmaceutical Limited | 600 | 2018-01-01 | 2017-11-17 |
| Effect of Ergocalciferol on Iron Metabolism in Individuals With Chronic Kidney Disease Ergocalciferol 50000 UNT, Placebo - CKD, Chronic Kidney Diseases | Phase 4 | Withdrawn | University of Alabama at Birmingham | 2018-01-01 | 2018-03-15 | |
| Effect of Iron on Cerebral Dopamine Receptor Density in Non-anaemic Premenopausal Women With Low Ferritin and Fatigue Iron Carboxymaltose, Sodium chloride 0.9% - Fatigue, Iron-deficiency | Phase 4 | Unknown | Albina Nowak, MD | 20 | 2017-10-23 | 2017-10-13 |
| Effect of IV Iron in Patients With Heart Failure With Preserved Ejection Fraction Ferric Carboxymaltose 50Mg/Ml Inj 15Ml, Saline Solution for Injection - Iron-deficiency, Heart Failure | Phase 4 | Completed | Charite University, Berlin, Germany | 40 | 2017-08-01 | 2024-05-31 |
| Iron Deficiency Anemia, Iron Supplementation and Genomic Stability in Infants Weekly Ferrous Sulfate, Daily Ferrous Sulfate - Anemia, Iron-deficiency | Phase 4 | Unknown | Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri | 204 | 2017-08-01 | 2019-02-15 |
| A Double Blind Randomised Placebo-controlled Trial to Assess the Role of Iron Repletion in Glucose Homeostasis. Ferric Carboxymaltose, 0.9% sodium chloride solution - Iron-deficiency, Iron Toxicity | Phase 4 | Terminated | Prof Gérard WAEBER | 32 | 2017-06-21 | 2020-03-26 |
| Changes in Myocardial Iron After Iron Administration Ferric carboymaltose, Placebo (Normal saline), Cardiac magnetic resonance - Heart Failure, Iron-deficiency | Phase 4 | Completed | Fundación para la Investigación del Hospital Clínico de Valencia | 53 | 2017-05-01 | 2019-07-30 |
Showing 20 of 22. Sign in to see all of them.
Anemia, Iron-Deficiency (22) · Heart Failure (5) · Iron Deficiencies (5) · Anemia (4) · Aortic Valve Stenosis (1) · Child Behavior Disorders (1) · Colitis, Ulcerative (1) · Crohn Disease (1) · Cystic Fibrosis (1) · Fatigue (1) · Glucose Metabolism Disorders (1) · Heart Failure, Systolic (1) · Hypophosphatemia (1) · Inflammatory Bowel Diseases (1) · Metabolic Side Effects of Drugs and Substances (1)
Anemia, Hypochromic (22) · Hematologic Diseases (22) · Hemic and Lymphatic Diseases (22) · Iron Metabolism Disorders (22) · Metabolic Diseases (22) · Nutritional and Metabolic Diseases (22) · Anemia (18) · Iron Deficiencies (17) · Cardiovascular Diseases (6) · Heart Diseases (6) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (3) · Digestive System Diseases (2) · Mental Disorders (2) · Nervous System Diseases (2)
ferric carboxymaltose (10) · Sodium Chloride (4) · Iron-Dextran Complex (2) · Lactoferrin (2) · Saline Solution (2) · ferrous sulfate (2) · sucrosomial iron (2) · Injections (1) · Iron (1) · Iron Chelating Agents (1) · Nutrition Assessment (1) · Vitamin D (1) · calcium D-pantothenate, L-cysteine drug combination (1) · ferric maltol (1) · ferrous fumarate (1)
South Valley University (2) · Albina Nowak, MD (1) · Cantonal Hospital, Baselland (1) · Charite University, Berlin, Germany (1) · Danone Specialized Nutrition Indonesia (1) · Deepanjan Bhattacharya (1) · Donat R. Spahn (1) · Fundación para la Investigación del Hospital Clínico de Valencia (1) · Hospital de Santa Cruz, Portugal (1) · Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri (1) · King's College Hospital NHS Trust (1) · Lee's Pharmaceutical Limited (1) · Leiden University Medical Center (1) · Mayo Clinic (1) · Prof Gérard WAEBER (1)
Switzerland (3) · United States (3) · Egypt (2) · United Kingdom (2) · Argentina (1) · Germany (1) · India (1) · Italy (1) · Netherlands (1) · Spain (1) · Sweden (1)
Albina Nowak, MD (1) · Ana Varea, Biochemist (1) · Donat R Spahn, Prof. Dr. (1) · Federico Capone, MD (1) · Gabriele Masini, MD PhD (1) · Julie Baughn, MD (1) · Kanya Mukhopadhyay, MD DM (1) · Kate Bramham (1) · Mohammad AM Ahmed, MD (1)
PMID 20819898, PMID 22071701, PMID 23230066, PMID 23505057, PMID 25119339, PMID 25406528, PMID 26192787, PMID 26394823, PMID 27557596, PMID 28382661, PMID 28612425, PMID 28659293, PMID 29607528, PMID 32067585, PMID 34913362, PMID 35301854, PMID 35706490, PMID 38296290, PMID 39671753, PMID 42261111
2016 (2), 2018 (1)